Daniel R. Mishell mainly focuses on Endocrinology, Internal medicine, Gynecology, Obstetrics and Ovulation. His is doing research in Luteinizing hormone, Hormone, Menstrual cycle, Follicular phase and Radioimmunoassay, both of which are found in Endocrinology. Daniel R. Mishell has included themes like Human placental lactogen and Gonadotropin in his Luteinizing hormone study.
His Gynecology study combines topics in areas such as Adverse effect, Randomized controlled trial, Anovulation, Gestation and Family planning. The Obstetrics study combines topics in areas such as Clinical research and Abortifacient, Abortion, Misoprostol. His Ovulation research integrates issues from Anesthesia, Luteal phase, Prospective cohort study and Infertility.
Daniel R. Mishell mainly investigates Internal medicine, Endocrinology, Gynecology, Obstetrics and Levonorgestrel. Endocrinology is a component of his Luteinizing hormone, Hormone, Ovulation, Endocrine system and Follicular phase studies. His research investigates the connection with Ovulation and areas like Medroxyprogesterone acetate which intersect with concerns in Physiology.
His study in Gynecology is interdisciplinary in nature, drawing from both Vaginal ring, Family planning, Clinical research, Progestin and Randomized controlled trial. His studies in Obstetrics integrate themes in fields like Abortion, Misoprostol and Gestation. His studies deal with areas such as Norgestrel, Surgery, Implant, Silastic and Metrorrhagia as well as Levonorgestrel.
His primary areas of investigation include Gynecology, Internal medicine, Endocrinology, Levonorgestrel and Obstetrics. His research in Gynecology intersects with topics in Vaginal ring, Family planning, Contraceptive patch, Regimen and Pill. His research links Transdermal with Internal medicine.
His study in Ovulation, Progestin, Hormone, Body mass index and Metabolic syndrome is carried out as part of his Endocrinology studies. In his study, which falls under the umbrella issue of Levonorgestrel, Intrauterine device is strongly linked to Sperm. The concepts of his Obstetrics study are interwoven with issues in Breastfeeding, Placebo, Mifepristone and Medical abortion.
His scientific interests lie mostly in Gynecology, Internal medicine, Levonorgestrel, Vaginal ring and Endocrinology. His Gynecology research includes elements of Family planning and Adverse effect. Particularly relevant to Progestogen is his body of work in Internal medicine.
His Levonorgestrel research is multidisciplinary, incorporating perspectives in Andrology, Uterus, Genitourinary system and Cervix. His work in Ovulation, Estrogen, Progestin and Body mass index is related to Endocrinology. The study incorporates disciplines such as Endometrium, Vagina and Luteinizing hormone in addition to Estrogen.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas
Steven Leibsohn;Gerrit d'Ablaing;Daniel R. Mishell;John B. Schlaerth.
American Journal of Obstetrics and Gynecology (1990)
Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes. Results of a multicentered randomized clinical trial. The Vitrectomy for Treatment of Macular Hole Study Group.
William R. Freeman;Stanley P. Azen;Jung W. Kim;Wael El-Haig.
Archives of Ophthalmology (1997)
Comparison of pharmacodynamic properties of various estrogen formulations.
Mashchak Ca;Lobo Ra;Dozono-Takano R;Eggena P.
American Journal of Obstetrics and Gynecology (1982)
Serum gonadotropin and steroid patterns during the normal menstrual cycle
Daniel R. Mishell;Robert M. Nakamura;Pier Giorgio Crosignani;Sergio Stone.
American Journal of Obstetrics and Gynecology (1971)
Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects.
Frank Z. Stanczyk;Janet P. Hapgood;Sharon Winer;Daniel R. Mishell.
Endocrine Reviews (2013)
Single luteal phase serum progesterone assay as an indicator of ovulation.
Robert Israel;Daniel R. Mishell;Sergio C. Stone;Ian H. Thorneycroft.
American Journal of Obstetrics and Gynecology (1997)
PROLONGED INTRAUTERINE CONTRACEPTION: A SEVEN-YEAR RANDOMIZED STUDY OF THE LEVONORGESTREL 20 mcg/DAY (LNg 20) AND THE COPPER T380 Ag IUDS
Irving Sivin;Janet Stern;Elsimar Coutinho;Carlos E.R. Mattos.
A decade’s experience with an individualized clomiphene treatment regimen including its effect on the postcoital test
Mathias Gysler;Charles M. March;Daniel R. Mishell;Edward J. Bailey.
Fertility and Sterility (1982)
A comparison of intravaginal misoprostol with prostaglandin E2 for termination of second-trimester pregnancy.
John K. Jain;Daniel R. Mishell.
The New England Journal of Medicine (1994)
Pharmacokinetics of depot medroxyprogesterone acetate contraception.
Journal of Reproductive Medicine (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: